OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced via its website. Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC.
Orchestra creates AI agents that help biotech companies manage the minutiae of drug discovery operations, from tracking finances to resolving scheduling issues with clinical trials.
Originally reported by TechCrunch. Read the full story at the original source.
Hackers aren't giving up at cracking the Playstation 5's latest firmware as evidenced by a new video showing an ...
Anthropic is having trouble securing enough cloud capacity from AWS, Google, and Microsoft, which increasingly see the C...
OpenAI has introduced a new "locked chats" feature to protect users' more sensitive conversations with ChatG...
A lawsuit brought by the OpenAI CEO's sister was dismissed after Anne Altman refused a medical exam.